Updated:
Aglaia Oncology Funds
Aglaia Oncology Funds manages early-stage oncology investments from Bilthoven, Netherlands.
Aglaia Oncology Funds
Aglaia is an oncology specialist investor which selects and matures early-stage breakthrough inventions that have the potential to transform cancer prevention, diagnosis and therapy.
General information
Firm type
Private Equity
Year founded
—
AUM
Undisclosed
Location
Region
Europe
Country
Netherlands
City
Bilthoven
Corporate office
Bilthoven, Netherlands
Sector focus
Frequently asked questions
What stages does Aglaia Oncology Funds target?
The firm focuses on early stage, seed, start-up, and spin-off opportunities.
Which sectors receive capital from Aglaia Oncology Funds?
Investments center on oncology and related life sciences areas.
Does Aglaia Oncology Funds commit to external funds or direct deals?
Available information shows a venture strategy without specified fund or direct allocation split.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: